SCHEMBL24933650

SCHEMBL24933650

C[C@H]1CO[C@@H](COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
HSD17B2 P37059 7/20 0.38
HSD17B1 P14061 6/20 0.38
GPR84 Q9NQS5 1/20 0.36
TP53 P04637 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 1/20 0.35
PPARG P37231 1/20 0.35
HIF1A Q16665 1/20 0.35
FFAR4 Q5NUL3 2/20 0.35
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933453 1.00 PARP1 (0.40) PARP1HSD17B2HSD17B1GPR84TP53
SCHEMBL24933655 1.00 PARP1 (0.40) PARP1HSD17B2HSD17B1GPR84TP53
SCHEMBL30240749 0.92 PARP1 (0.41) PARP1HSD17B2HSD17B1TP53MAPT
SCHEMBL24933022 0.91 PARP1 (0.41) PARP1HSD17B2HSD17B1TP53MAPT
SCHEMBL24933041 0.88 PARP1 (0.39) PARP1HSD17B2HSD17B1TP53MAPT
SCHEMBL24933744 0.87 HSD17B1 (0.36) PARP1HSD17B2HSD17B1FFAR4PRKAB2
SCHEMBL24933645 0.87 HSD17B1 (0.36) PARP1HSD17B2HSD17B1FFAR4PRKAB2
SCHEMBL24933415 0.87 HSD17B1 (0.36) PARP1HSD17B2HSD17B1FFAR4PRKAB2
SCHEMBL24933750 0.87 HSD17B1 (0.36) PARP1HSD17B2HSD17B1FFAR4PRKAB2
SCHEMBL24933551 0.86 GPR84 (0.42) PARP1HSD17B2HSD17B1GPR84MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed